e-Therapeutics Appoints Daniel Elger as CFO
e-Therapeutics, a pioneering network pharmacology company focused on drug discovery and development, has appointed Dr Daniel Elger as chief financial officer (CFO).
Previously, Elger was vice president, marketing and communications at cancer drug developer Antisoma. He joined that company in 2002 and served on its senior management team from 2005, playing significant roles in corporate strategy, fundraisings and the acquisition of two US biotech companies. He also directed the investor relations strategy for the company.
Before Antisoma, Elger was a programme director for major pharmaceutical companies at a leading marketing and communications agency. He holds a BA in Physiological Sciences (Medicine) and a PhD in cancer cell biology, both from Oxford University.